Predictive value on advance hodgkin lymphoma treatment outcome of end‐of treatment FDG PET/CT in the HD0607 clinical trial-Reference-Cited by-同舟云学术

Predictive value on advance hodgkin lymphoma treatment outcome of end‐of treatment FDG PET/CT in the HD0607 clinical trial

Published:2023-01-04 Issue: Volume: Page:
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Biggi Alberto¹,Chauvie Stephane²^ORCID,Fallanca Federico³,Guerra Luca⁴,Bergesio Fabrizio²,Menga Massimo⁵,Bianchi Andrea¹,Gregianin Michele⁶,Chiaravalloti Agostino⁷,Schillaci Orazio⁷,Pavoni Chiara⁸,Patti Caterina⁹,Picardi Marco¹⁰,Romano Alessandra¹¹,Schiavotto Corrado¹²,Sorasio Roberto¹³,Viviani Simonetta¹⁴,La Nasa Giorgio¹⁵,Trentin Livio¹⁶^ORCID,Rambaldi Alessandro⁸,Gallamini Andrea¹⁷

Affiliation:

1. Nuclear Medicine Division Santa Croce e Carle Hospital Cuneo Italy

2. Medical Physics Division Santa Croce e Carle Hospital Cuneo Italy

3. Nuclear Medicine Division IRCSS Ospedale San Raffaele Milano Italy

4. Nuclear Medicine Division Ospedale San Gerardo Monza Italy

5. Nuclear Medicine Division Ospedale Trieste Trieste Italy

6. Nuclear Medicine Division IOV Castelfranco Veneto Italy

7. Nuclear Medicine Division Tor Vergata University Roma Italy

8. Haematology Division ASST Papa Giovanni XXIII Bergamo Italy

9. Haematologiy. Division V. Cervello Hospital Palermo Italy

10. Clinical Medicine and Surgery Department Federico II University Naples Italy

11. Hematology Division Policlinico Vittorio Emanuele Hospital Catania Italy